Accelerated Trial-Sourcing
Consumers with chronic diseases and other conditions are pioneering the Accelerated Trial-Sourcing movement as they use digital tools to find one another, complete the first stage of discovery to prepare for a clinical study in real time, and recruit/entice the right pharmaceutical firms or other researchers to conduct the research.
Trend Longevity Rating
matured and remains highly relevant, even where the details changed
How this trend held up
Decentralized and patient-centered clinical trials became mainstream, accelerated further by pandemic-era necessity and formalized in FDA guidance on decentralized trials in the 2020s; real-world evidence generated outside traditional trial settings is now formally used in the FDA approval process. But PatientsLikeMe, the book's central example of patient-led research, lost its independence in 2019 when the Trump administration forced a sale away from its Chinese investor, landing the platform inside UnitedHealth Group — one of the country's largest traditional insurers, and an odd ending for a company built on the promise of patients bypassing institutional gatekeepers. The movement succeeded; its flagship symbol was absorbed by the establishment it was founded to challenge.
Every past trend prediction is re-reviewed and graded with a Trend Longevity Rating, measuring how much each originally curated trend still matters years later.
